144 related articles for article (PubMed ID: 3101140)
1. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.
Duncan W; Quilty PM
Radiother Oncol; 1986 Dec; 7(4):299-310. PubMed ID: 3101140
[TBL] [Abstract][Full Text] [Related]
2. Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy.
Quilty PM; Kerr GR; Duncan W
Radiother Oncol; 1986 Dec; 7(4):311-21. PubMed ID: 3101141
[TBL] [Abstract][Full Text] [Related]
3. Do normal mucosal biopsies predict prognosis in patients with transitional cell carcinoma of bladder treated by radical radiotherapy?
Quilty PM; Hargreave TB; Smith G; Duncan W
Br J Urol; 1987 Mar; 59(3):242-7. PubMed ID: 3567486
[TBL] [Abstract][Full Text] [Related]
4. Treatment of superficial (T1) tumours of the bladder by radical radiotherapy.
Quilty PM; Duncan W
Br J Urol; 1986 Apr; 58(2):147-52. PubMed ID: 3083903
[TBL] [Abstract][Full Text] [Related]
5. Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution.
Tonoli S; Bertoni F; De Stefani A; Vitali E; De Tomasi D; Caraffini B; Scheda A; Bertocchi M; Somensari A; Buglione M; Magrini SM
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):52-9. PubMed ID: 16477920
[TBL] [Abstract][Full Text] [Related]
6. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy and cystectomy for T3 bladder carcinoma.
Hall RR; Heath AB
Br J Urol; 1981 Dec; 53(6):598-601. PubMed ID: 7317748
[TBL] [Abstract][Full Text] [Related]
8. Assessment of factors influencing the outcome of radiotherapy for bladder cancer.
Davidson SE; Symonds RP; Snee MP; Upadhyay S; Habeshaw T; Robertson AG
Br J Urol; 1990 Sep; 66(3):288-93. PubMed ID: 2119844
[TBL] [Abstract][Full Text] [Related]
9. The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation.
Quilty PM; Duncan W
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1735-42. PubMed ID: 3093414
[TBL] [Abstract][Full Text] [Related]
10. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.
Gospodarowicz MK; Hawkins NV; Rawlings GA; Connolly JG; Jewett MA; Thomas GM; Herman JG; Garrett PG; Chua T; Duncan W
J Urol; 1989 Dec; 142(6):1448-53; discussion 1453-4. PubMed ID: 2585617
[TBL] [Abstract][Full Text] [Related]
11. Split-course radiotherapy for urinary bladder cancer.
Salminen E
Radiother Oncol; 1989 Aug; 15(4):327-31. PubMed ID: 2508191
[TBL] [Abstract][Full Text] [Related]
12. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control.
Quilty PM; Duncan W
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):853-60. PubMed ID: 2424878
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy for transitional cell bladder carcinoma. A ten-year experience.
Chougule P; Aygun C; Salazar O; Young J; Prempree T; Amin P
Urology; 1988 Aug; 32(2):91-5. PubMed ID: 3135646
[TBL] [Abstract][Full Text] [Related]
14. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
[TBL] [Abstract][Full Text] [Related]
15. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
Yavuz AA; Yavuz MN; Ozgur GK; Colak F; Ozyavuz R; Cimsitoglu E; Ilis E
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):734-45. PubMed ID: 12788179
[TBL] [Abstract][Full Text] [Related]
16. [Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis].
Escudero Barrilero A; Allona A; Berenguer A; Burgos J; Castañeda A; Negrin A; Tellez M
Actas Urol Esp; 1991; 15(2):124-38. PubMed ID: 1807106
[TBL] [Abstract][Full Text] [Related]
17. Predicting the outcome of radical radiotherapy for invasive bladder cancer.
Vale JA; A'Hern RP; Liu K; Hendry WF; Whitfield HN; Plowman PN; Sowter C; Slavin G
Eur Urol; 1993; 24(1):48-51. PubMed ID: 8365439
[TBL] [Abstract][Full Text] [Related]
18. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.
Pollack A; Zagars GK; Swanson DA
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):267-77. PubMed ID: 7928456
[TBL] [Abstract][Full Text] [Related]
19. Results of implantation for T1 and T2 bladder tumours.
Battermann JJ; Tierie AH
Radiother Oncol; 1986 Feb; 5(2):85-90. PubMed ID: 3085168
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
